Skip to main content

Published locations for FDA panel recommends informed consent, labeling changes to address morcellator risk

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. FDA panel recommends informed consent, labeling changes to address morcellator risk

User login

  • Reset your password
  • /content/fda-panel-recommends-informed-consent-labeling-changes-address-morcellator-risk
  • /obgynnews/article/84454/gynecology/fda-panel-recommends-informed-consent-labeling-changes-address
  • /acssurgerynews/article/84454/gynecology/fda-panel-recommends-informed-consent-labeling-changes
  • /oncologypractice/article/84454/gynecology/fda-panel-recommends-informed-consent-labeling-changes
  • /obgyn/article/84454/gynecology/fda-panel-recommends-informed-consent-labeling-changes-address
  • /hematology-oncology/article/84454/gynecology/fda-panel-recommends-informed-consent-labeling-changes
  • /surgery/article/84454/gynecology/fda-panel-recommends-informed-consent-labeling-changes-address